Xanomeline Enteric Capsule (Karuna Therapeutics)

呫诺美林肠溶胶囊 (Karuna Therapeutics)

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameXanomeline Enteric Capsule (Karuna Therapeutics)
Drug Alias NameHexyloxy-TZTPKarX-ECXanomelineMemcorLumeron +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M4 agonistsMuscarinic acetylcholine receptor M1 agonists
TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M4
Therapy Area/IndicationsAgitationSchizophreniaPsychotic Disorders +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[30] 
CombinationsYes
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb (China) Investment Co LtdKaruna Therapeutics Inc +[4] 
Inactive CompaniesN/A
Active IndicationsAgitationPsychotic DisordersAutism Spectrum Disorder +[4] 
Inactive IndicationsSchizophreniaMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A